lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.
To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with lauric acid
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Orellana B M et al. | Oxidative stress, microsomal and peroxisomal fatty acid oxidation in the liver of rats treated with acetone. | 2001 | Comp. Biochem. Physiol. C Toxicol. Pharmacol. | pmid:11301292 |
Aoki T et al. | Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia. | 2001 | Arzneimittelforschung | pmid:11304935 |
Echtay KS et al. | Role of intrahelical arginine residues in functional properties of uncoupling protein (UCP1). | 2001 | Biochemistry | pmid:11318647 |
Cunha MT et al. | Effect of salts and surfactants on the partitioning of Fusarium solani pisi cutinase in aqueous two-phase systems of thermoseparating ethylene oxide/propylene oxide random copolymer and hydroxypropyl starch. | 2000 | Bioseparation | pmid:11321518 |
Glover ED | 2000 Research Laureate Medallion Award. | Am J Health Behav | pmid:11322613 | |
Simonyan RA et al. | Cold-induced changes in the energy coupling and the UCP3 level in rodent skeletal muscles. | 2001 | Biochim. Biophys. Acta | pmid:11334791 |
Stott PW et al. | Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. | 2001 | Int J Pharm | pmid:11337176 |
Ichihara K et al. | Fatty acid omega and (omega-1)-Hydroxylation in rabbit intestinal mucosa microsomes. | 1979 | J. Biochem. | pmid:113393 |
Kothari HV | Purification and properties of aortic cholesteryl ester hydrolase. | 1975 | Lipids | pmid:1134220 |
Park SJ et al. | Biosynthesis of poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) by metabolically engineered Escherichia coli strains. | 2001 | Biotechnol. Bioeng. | pmid:11353413 |